Unexpected Clinical Outcome for Myxoinflammatory Fibroblastic Sarcoma, When Should They Be Considered High Grade?

• Principais autores: Brian K. Sparkman MD, MS (Autor), Tuong Vi V. Nguyen MS (Autor), Steven Christopher Smith MD, PhD (Autor), Harry D. Bear MD, PhD (Autor)
• Formato: Livro
• Publicado em: SAGE Publishing, 2023-10-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Myxoinflammatory fibroblastic sarcoma (MIFS) is a rare tumor of soft tissue. It typically presents as a low-grade sarcoma with myxoid stroma, has a predilection for distal extremities, and displays a high propensity for local recurrence, but low metastatic potential. The risk factors associated with...